NILOTINIB vs NIRSEVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NILOTINIB vs NIRSEVIMAB: Safety Overview
| Metric | NILOTINIB | NIRSEVIMAB |
|---|---|---|
| Total FAERS Reports | 23,171 | 247 |
| Deaths Reported | 4,543 | 5 |
| Death Rate | 19.6% | 2.0% |
| Hospitalizations | 4,846 | 149 |
| Average Patient Age | 56.5 yrs | 0.3 yrs |
| % Female Patients | 47.7% | 42.3% |
| FDA Approval Date | Dec 15, 2025 | N/A |
| Manufacturer | Novadoz Pharmaceuticals LLC | Sanofi Pasteur Inc. |
| Route | ORAL | INTRAMUSCULAR |
| Marketing Status | Prescription | N/A |